Related content

Pyrosequencing™-based screening for genetic polymorphisms in cytochrome P450 2B6 of potential clinical relevance

By Rohrbacher Maren   Kirchhof Anja   Geisslinger Gerd   Lötsch Jörn  

Pharmacogenomics, Vol. 7, Iss. 7, 2006-10 ,pp. : 995-1002

Future Medicine

Access to resources Recommend Favorite

Gene Variants and Haplotypes Modifying Transcription Factor Binding Sites in the Human Cyclooxygenase 1 and 2 (PTGS1 and PTGS2) Genes

By  

Current Drug Metabolism, Vol. 15, Iss. 2, 2014-02 ,pp. : 182-195

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Polymorphisms in the Cyclooxygenase 2 (COX-2) Gene and Risk of Breast Cancer in a Chinese Population

By Gao Jun   Ke Qiao   Ma Hong-Xia   Wang Yan   Zhou Yan   Hu Zhi-Bin   Zhai Xiang-Jun   Wang Xue-Chen   Qing Jian-Wei   Chen Wen-Sen   Jin Guang-Fu   Liu Ji-Yong   Tan Yong-Fei   Wang Xin-Ru   Shen Hong-Bing  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 11, 2007-01 ,pp. : 908-915

Taylor & Francis Ltd

Access to resources Recommend Favorite

Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs: Clinical Relevance

By Kirchheiner Julia   Roots Ivar   Goldammer Mark   Rosenkranz Bernd  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1209-1225

Adis International

Access to resources Recommend Favorite

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2253-2266

Bentham Science Publishers

Access to resources Recommend Favorite